Profile
Mr. Stewart Sharpe is Vice President-Commercial Operations at Circassia Pharmaceuticals Plc and a Member at The Chartered Institute of Marketing.
He is on the Board of Directors at Oxfordshire Bioscience Network Ltd.
Mr. Sharpe was previously employed as Head-Commercial & Business Development by OSI Pharmaceuticals.
He received his undergraduate degree from the University of Greenwich.
Stewart Sharpe active positions
| Companies | Position | Start |
|---|---|---|
The Chartered Institute of Marketing
The Chartered Institute of Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Stewart Sharpe
| Companies | Position | End |
|---|---|---|
OSI Pharmaceuticals (UK) Ltd. | Corporate Officer/Principal | - |
OBN (UK) Ltd.
OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a membership organization that supporting and bringing together the UK’s innovative life sciences companies, corporate partners and investors | Director/Board Member | - |
| NIOX GROUP PLC | Chief Operating Officer | - |
Training of Stewart Sharpe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Greenwich
University of Greenwich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chartered Institute of Marketing
The Chartered Institute of Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSI Pharmaceuticals (UK) Ltd. | |
OBN (UK) Ltd.
OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a membership organization that supporting and bringing together the UK’s innovative life sciences companies, corporate partners and investors | Commercial Services |
Niox Group Plc
Niox Group Plc Medical/Nursing ServicesHealth Services Develops immuno therapies to control immune system responses | Health Services |
- Stock Market
- Insiders
- Stewart Sharpe
















